Astellas and IBL Concludes Co-Research Agreement Regarding Pharmaceutical Applications of Recombinant Human Proteins Made Using transgenic Silkworms Tokyo, December 25, 2013 - Astellas Pharma Inc. ("Astellas") and Immuno-Biological ...
UK based Prosonix has signed a collaborative research agreement with Imperial College London to accelerate the development of engineered multi-component particles (MCPs) as respiratory medicines. As part of the collaboration, Prosonix ...
Tags: collaborative research agreement, multi-component particles